You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

CLINICAL TRIALS PROFILE FOR KIMMTRAK

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for KIMMTRAK

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT06070012 ↗	Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma	Not yet recruiting	Immunocore Ltd	Phase 2	2024-06-30	This is a phase II open-label, single-arm, multi-center study of tebentafusp in HLA- A*0201 positive previously untreated (1L) untreated metastatic uveal melanoma (mUM) with an integrated circulating tumor DNA (ctDNA) biomarker.
NCT06070012 ↗	Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma	Not yet recruiting	Diwakar Davar	Phase 2	2024-06-30	This is a phase II open-label, single-arm, multi-center study of tebentafusp in HLA- A*0201 positive previously untreated (1L) untreated metastatic uveal melanoma (mUM) with an integrated circulating tumor DNA (ctDNA) biomarker.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for KIMMTRAK

Condition Name

Chart
Table

Condition Name for KIMMTRAK
Intervention	Trials
Uveal Melanoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for KIMMTRAK
Intervention	Trials
Uveal Neoplasms	1
Melanoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for KIMMTRAK

Trials by Country

Map
Table

Trials by Country for KIMMTRAK
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for KIMMTRAK
Location	Trials
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for KIMMTRAK

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for KIMMTRAK
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for KIMMTRAK
Clinical Trial Phase	Trials
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KIMMTRAK

Sponsor Name

Chart
Table

Sponsor Name for KIMMTRAK
Sponsor	Trials
Immunocore Ltd	1
Diwakar Davar	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for KIMMTRAK
Sponsor	Trials
Industry	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.